SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-106939
Filing Date
2016-03-22
Accepted
2016-03-22 18:01:35
Documents
2
Period of Report
2016-03-22

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2906
2 EX-24.1 ex-24d1.htm EX-24.1 9217
  Complete submission text file 0001104659-16-106939.txt   13527
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37719 | Film No.: 161521947